The Nobel Assembly at Karolinska Institutet has awarded the 2024 Nobel Prize in Physiology or Medicine jointly to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Victor Ambros is Silverman Professor of Natural Science at the University of Massachusetts Medical School, Worcester, MA, and Gary Ruvkun is Professor of Genetics at Massachusetts General Hospital and Harvard Medical School.

MicroRNA is a new class of tiny RNA molecules that play a crucial role in gene regulation. It is now known that the human genome codes for over one thousand microRNAs.

The discovery revealed an entirely new dimension to gene regulation as microRNAs are proving to be fundamentally important for how organisms develop and function.

In the 1960s, it was shown that specialised proteins, known as transcription factors, can bind to specific regions in DNA and control the flow of genetic information by determining which mRNAs are produced.

Since then, thousands of transcription factors have been identified, and for a long time it was believed that the main principles of gene regulation had been solved.

Victor Ambros and Gary Ruvkun were postdoctoral fellows in the laboratory of Robert Horvitz in the 1980s, who was awarded the Nobel Prize in 2002, alongside Sydney Brenner and John Sulston.

In 1993, they published unexpected findings describing a new level of gene regulation, which turned out to be highly significant and conserved throughout evolution.

Abnormal regulation by microRNA can contribute to cancer, and mutations in genes coding for microRNAs have been found in humans, causing conditions such as congenital hearing loss, eye and skeletal disorders. Mutations in one of the proteins required for microRNA production result in the DICER1 syndrome, a rare but severe syndrome linked to cancer in various organs and tissues.

Diana Spencer, Senior Digital Content Editor, DDW